The first cell-based Influenza vaccine in Australia has been approved for use in adults and children aged two years and older. In a statement written to the Epoch Times, the Therapeutic Goods Administration (TGA) wrote that the Flucelvax Quad vaccine is the first and only cell-based flu vaccine available in Australia and approved for Australians two years of age and older. “We want to make sure Australians have access to cell-based influenza vaccine technology,” said Jonathan Anderson, the head of the vaccine manufacturer in Medical Affairs for the Asia Pacific. “Flucelvax Quad offers a choice when it comes to flu vaccination and it is important for patients to discuss options with their healthcare provider before a decision is made.” The news comes after TGA approved the four-strained vaccine for Australians aged nine and older previously in 2020. Seqirus UK Limited is developing the vaccine; the company has bases in UK, …